TURKISH JOURNAL OF HEMATOLOGY, vol.33, no.4, pp.273-280, 2016 (SCI-Expanded)
Objective: In this study, we aimed to investigate the efficacy and safety of azacitidine (AZA) in elderly patients with acute myeloid leukemia (AML), including patients with >30% bone marrow (BM) blasts.